Marco Catucci winner of the Collaborative and Licensing Opportunity Presentations 2023
Marco Catucci interview on BioFIT 2023
What brought you to BioFIT? What are the objectives of your project? What does the award mean for your innovation?
Find out more about Ospedale San Raffaele and its involvement in Biofit 2023
San Raffaele is a Scientific Institute of Hospitalisation and Care and a University Hospital of international importance and high specialisation. It is a place that combines high-tech, state-of-the-art care and a multidisciplinary approach.
The San Raffaele University and Research Hospital, represented by Marco Catucci, won the Start-Up Slams award for the most promising technology for their CAR/TCR T Cell therapy project. This award was a unique opportunity for the project:
“It was an honour to present the CAR-T cell therapy developed by our institute here in this really important event. I think that this event and the pitch give me the possibility to promote this project and to make it visible to very important pharmaceutical companies that I hope will be interested in licensing this technology”.
About the pitch sessions BioFIT 2024
Start-up Slams
The Start-up Slams are a great opportunity for young companies (and particularly start-ups seeking to raise a seed or a Series A financing round) to showcase their project in front of potential partners and investors in the Life Sciences field.
Collaborative and Licensing Opportunity Presentations
The Collaborative and Licensing Opportunity Presentations are a great opportunity for TTOs, universities, research institutes and companies to showcase their early-stage technologies in front of potential partners in the Life Sciences field, in order to entail a collaborative project and/or a licensing deal.
Animal Health Presentations
The Animal Health Presentations are a great opportunity for young companies, TTOs, universities, research institutes and companies to showcase their innovative project in front of potential partners and investors in the Animal Health sector.